American Journal of Kidney Diseases
Volume 40, Issue 3 , Pages 439-446, September 2002

Meta-analysis of subcutaneous versus intravenous epoetin in maintenance treatment of anemia in hemodialysis patients☆☆☆★

Work was performed at Roche Bioscience, Palo Alto, CA, and Acumen, LLC, Burlingame, CA.

Division of Nephrology and Hypertension, Henry Ford Hospital, Detroit, MI; Department of Clinical Pharmacy, University of California San Francisco, San Francisco; Acumen, LLC, Burlingame; and Stanford University School of Medicine, Stanford, CA.

Received 30 January 2002; received in revised form 13 May 2002; accepted 13 May 2002.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Supported in part by F. Hoffmann-La Roche Ltd, Switzerland.

☆☆ Address reprint requests to John Hornberger, MD, MS, Acumen, LLC, 1415 Rollins Rd, Ste 110, Burlingame, CA 94010. E-mail: jhornberger@acumen-llc.com

★ 0272-6386/02/4003-0001$35.00/0

PII: S0272-6386(02)00066-5

doi:10.1053/ajkd.2002.34881

Refers to article:

  • Preaching and practice: Evidence-based medicine and the accountability of nephrologists within the health care system. The implications of the findings of the cost-saving potential of subcutaneous versus intravenous epoetin therapy

    Adeera Levin
    American Journal of Kidney Diseases September 2002 (Vol. 40, Issue 3, Pages 662-663)

American Journal of Kidney Diseases
Volume 40, Issue 3 , Pages 439-446, September 2002

Article Tools

* Image Usage & Resolution